Drug Resistance, Neoplasm
Conditions
Interventions
Observational study with biological sample collection in which patients indicated for biopsy (without a confirmed diagnosis), diagnosed with invasive neoplasms who have indication of systemic therapy
I03.784
Sponsors
Ziel Biosciences Pesquisa, Desenvolvimento e Diagnóstico LTDA
Ziel Biosciences Pesquisa, Desenvolvimento e Diagnóstico LTDA
Eligibility
Inclusion criteria
Inclusion criteria: Patients of both genders diagnosed with hematological and solid neoplasms; specially breast; lung; colorectal; stomach; ovarian; melanoma and sarcoma; with indication of systemic therapy as part of their treatment or neoadjuvant therapy will be invited to participate in the study; as patients who will undergo biopsies with suspicion of neoplasia; but still without a confirmed diagnosis
Exclusion criteria
Exclusion criteria: Patients with benign tumors confirmed by anatomopathological evaluation will be excluded from the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to find a significant difference between the response rate compared to the historical control of patients diagnosed with neoplasia. | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival and disease-free survival are expected to be evaluated as a secondary outcome. | — |
Countries
Brazil
Contacts
Public ContactCaroline de Farias
Ziel Biosciences Pesquisa, Desenvolvimento e Diagnóstico LTDA
Outcome results
None listed